Agoracom Blog Home

Posts Tagged ‘small cap’

Else $BABY.ca $BABYF Signs Agreement to Expand into 159 Vitamin Cottage Stores Across 20 States $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 8:50 AM on Wednesday, April 14th, 2021
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Announced that it will expand distribution of it Plant-Based Complete Nutrition for Toddlers into 159 Natural Grocers by Vitamin Cottage stores across 20 states as of May 2021

VANCOUVER, BC , April 14, 2021 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY.V) (OTCQX: BABYF) (FSE: 0YL.F) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company , announces that it will expand distribution of it Plant-Based Complete Nutrition for Toddlers into 159 Natural Grocers by Vitamin Cottage stores across 20 states as of May 2021.

“Launching at Natural Grocers by Vitamin Cottage drives significant and strategic distribution for the brand. We are particularly excited by the alignment between this retailer and with our brand, both focusing on helping people through sustainable, organic nutrition solutions, said Hamutal Yitzhak , Else CEO and Co-Founder. “We are eager to bring real, organic and whole food-based, clean label solutions to families in this region,” she added.

About Natural Grocers by Vitamin Cottage

Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is one of the leading natural food grocers in the US, with 159 stores in 20 states west of the Mississippi river. Founded in 1955, Natural Grocers is an expanding specialty retailer of natural and organic groceries, body care products, and dietary supplements. The products sold by Natural Grocers must meet strict quality guidelines and may not contain artificial colors, flavors, preservatives or sweeteners, or partially hydrogenated or hydrogenated oils. The Company sells only USDA certified organic produce and exclusively pasture-raised, non-confinement dairy products, and free-range eggs. Natural Grocers’ flexible smaller-store format allows it to offer affordable prices in a shopper-friendly, safe, and convenient retail environment. The Company also provides extensive free science-based Nutrition Education programs to help customers make informed health and nutrition choices.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board  members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies,  and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents.  Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate.  Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Empower Clinics $CBDT.ca $EPWCF Kai Medical Lab Receives Order for Up To 5,000 Covid-19 Tests from Two Film & Television Productions in Excess Of $750,000 $DMTK $LMD.ca $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM-JC at 8:36 AM on Wednesday, April 14th, 2021

  • Announced that Kai Medical Laboratory has received an order for COVID-19 RT-PCR tests that is anticipated to be in excess of $CAD 750,000 from two new film and television productions.

VANCOUVER, BC / April 14, 2021 / EMPOWER CLINICS INC. (CSE:CBDT) (Frankfurt:8EC) (OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce that Kai Medical Laboratory (“KAI”) has received an order for COVID-19 RT-PCR tests that is anticipated to be in excess of $CAD 750,000 from two new film and television productions.

5,000 TEST ORDER FOR FILM & TELEVISION PRODUCTIONS REPRESENTS REPEAT ORDER BASED ON CONSISTENT PERFORMANCE OF KAI MEDICAL LAB

In early October, shortly after the acquisition of KAI, Empower announced an agreement to process approximately 1,000 COVID-19 RT-PCR tests for a major film & TV production over a 30-day period, with the possibility of more business upon successful completion of the initial tests.

On November 16, 2020 KAI received a repeat and record COVID-19 testing order for approximately 9,000 units in excess of $CAD 1,000,000 over a four-month period.

Today’s announcement represents a repeat Purchase Order of approximately 5,000 units to be processed over just a two-month period. The total revenue from this order is anticipated to be in excess of $CAN 750,000.

“Our team at KAI continues to deliver the type of performance to Tier-1 clients that is worthy of significant repeat business that serves as unequivocal validation of our capabilities,” said Steven McAuley, Chairman & CEO of Empower. “To this end, the magnitude of KAI’s growth and success cannot be overstated as it continues to focus on very active business development and product development, setting a path toward significant North American growth in the midst of tripling its size. KAI is well on its way to becoming a national brand supported by our strong working capital position and a team dedicated to performance.”

As of September 1st, KAI has already processed tests for multiple different film and television productions in key US markets including Los Angeles, Atlanta, New York, Dallas, earning the highest confidence of the industry.

KAI MEDICAL LABORATORY NOW EXPANDING TO TRIPLE CURRENT SIZE IN ANTICIPATION OF ANTICIPATED RAPID TEST GROWTH

On February 16th, Empower announced “KAI Laboratory Now Tripling in Size in Anticipation of Test Volumes by End of Q1”

KAI continues to progress on the design and build out of the laboratory expansion to prepare to meet upcoming demand in a number of areas. First, the continued processing of RT-PCR tests for film & television productions, commercial accounts and enterprise level clients. Second, the full e-commerce impact of KaiTests.com and the national direct-to-consumer marketing programs for KAI Saliva, an FDA, EUA authorized and Health Canada approved at-home Saliva COVID-19 RT-PCR Test. KAI Saliva provides travellers, both foreign and domestic with a simple, fully compliant method to obtain an RT-PCR test and test result prior to arriving or coming back into Canada and USA, or arriving in other countries that have similar executive travel orders.

Finally, KAI Labs continues the development of new direct-to-consumer test protocols that will expand the product offers on Kaitests.com throughout 2021 and beyond.

McAuley added “With each passing month Empower gains more strength and velocity in every aspect of our business from KAI Lab in Dallas to our rapidly expanding clinic operations in Canada and our direct-to-consumer products such as KAI Saliva. All of which are amply funded well into the future with our strongest balance sheet ever thanks to the receipt of more than $12,000,000 in warrant conversions as of last month. We are on a path, a trajectory towards building a great health and wellness company across North America, and I look forward to providing our shareholders with further specifics.”

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/759019-empower-clinics-kai-medical-lab-receives-order-for-up-to-5-000-covid-19-tests-from-two-film-television-productions-in-excess-of-750-000/messages/2311867#message

ImagineAR $IP.ca $IPNFF Announces Three Year White Label Mobile APP Revenue Partnership Agreement with Automotive Industries (AI) Trade Publication $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

Posted by AGORACOM-JC at 8:33 AM on Tuesday, April 13th, 2021
  • Announce a three year revenue white label mobile app partnership agreement with Automotive Industries (AI) trade publication
  • Automotive Industries print audience plus Ai’s online readership are the who’s who of automotive decision-making, including major carmakers, system suppliers, 1st tier and major 2nd tier award winning supplier companies.

VANCOUVER, BC , April 13, 2021 – ImagineAR (CSE: IP) (OTCQB: IPNFF) an Augmented Reality Company that enables sports teams, brands and businesses to instantly create mobile phone AR immersive engagement campaigns, is pleased to announce a three year revenue white label mobile app partnership agreement with Automotive Industries (AI) trade publication.  Automotive Industries print audience plus Ai’s online readership are the who’s who of automotive decision-making, including major carmakers, system suppliers, 1st tier and major 2nd tier award winning supplier companies.

Automotive Industries (Ai) Publisher, John Larkin said “The automotive industry is often considered to be one of the most global of all industries, by 2022 there are expected to be 1 billion+ cars on the planet. The car makers are looking for the next innovation to benefit their consumers, their communication & their marketing partnerships.  We believe computer vision AR and Alen Paul Silverrstieen’s team at ImagineAR are bringing the automotive industry and the world consumers of automobiles one of the best media communication assets since the introduction of the mobile phone.”

Alen Paul Silverrstieen, CEO & President of ImagineAR, stated “This is our first publishing partnership and solely focused on the business-to-business marketplace.  John understands the revenue impact AR can deliver to his industry publication by increasing engagement and activations around the world leveraging our white-label mobile app platform with integrated content subscription channels.  We are excited to transform the publishing business with Automotive Industries.”

“Hype Sports Innovation has been an amazing opportunity for ImagineAR to demonstrate our comprehensive Augmented Reality Platform to leading sports clubs, broadcasters, and publishers around the world.  After being selected by 17 different organizations, we are excited to announce the first executed contract from the HYPE Virtual Accelerator 2021”, continued Mr. Silverrstieen.

About Automotive Industries
Automotive Industries (Ai) is the world’s oldest continually published trade publication covering the automaking business. It was founded in November 1895 as “The Horseless Age,” the first magazine created to cover the world’s transition from horse-drawn conveyances to those powered by the new internal combustion engine. The magazine changed its name to “The Automobile” in July 1909 , an era when gasoline, steam and electricity all vied for preeminence in motive power.

The magazine’s present name was established in November 1917 . The title was briefly amended to “Automotive and Aviation Industries” during the World War II years, as the magazine expanded its coverage of technologies and production methods to include the aircraft industry, in which many automakers participated.

Automotive Industries is devoted to providing a global coverage on all aspects of the automobile marketplace, with an emphasis on the people, products and processes that shape the industry. Automotive Industries provides manufacturers and suppliers with in-depth news, information, insight and analysis on the global events that affect the auto industry. Visit Ai at www.i.ai

Read More: https://agoracom.com/ir/Imaginear/forums/discussion/topics/758938-imaginear-announces-three-year-white-label-mobile-app-revenue-partnership-agreement-with-automotive-industries-ai-trade-publication/messages/2311715#message

Empower $CBDT.ca $EPWCF Appoints Kai Medical Laboratory President Yoshi Tyler To Board of Directors $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 8:29 AM on Tuesday, April 13th, 2021
  • Announced it has appointed Ms. Yoshi Tyler to its board of directors.
  • With a professional and entrepreneurial background in healthcare, Ms. Tyler has more than 13 years of experience providing leadership at Pfizer, Inc., a Fortune 500 pharmaceutical company.
  • This experience has provided her with in-depth knowledge and industry insights to found and lead Kai Medical Laboratory towards unprecedented growth.

VANCOUVER, BC / April 13, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens – is pleased to announce it has appointed Ms. Yoshi Tyler to its board of directors.

With a professional and entrepreneurial background in healthcare, Ms. Tyler has more than 13 years of experience providing leadership at Pfizer, Inc., a Fortune 500 pharmaceutical company. This experience has provided her with in-depth knowledge and industry insights to found and lead Kai Medical Laboratory towards unprecedented growth. Empower fully acquired Kai Medical Laboratory in October 2020.

“We are delighted to welcome Yoshi as a valued addition to our board of directors,” said Steven McAuley, Chairman & CEO of Empower. “Having diverse leadership continues to improve our company and since our acquisition of Kai Medical Laboratory, Yoshi has led her team to surpass initial growth forecasts and demonstrated an incredible work ethic and passion for excellence. I am privileged to now count Yoshi as a fellow board member in recognition of her talent, performance and passion.”

“I’m thrilled to be contributing to the growth of Empower at another level of the company,” said Yoshi Tyler. “After only a few months as part of the Empower team, I’ve witnessed the benefits of our synergies and know firsthand about the incredible potential we have to become a leading integrated health care company in North America.”

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

ABOUT EMPOWER:

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/758939-empower-appoints-kai-medical-laboratory-president-yoshi-tyler-to-board-of-directors/messages/2311716#message

Oasis Digital Studios and Apex Comics Group partner with Comic-Book Industry Legends for New Multimedia Experiences and NFTs $MOS.ca $MOGO.ca $CTZ.ca

Posted by AGORACOM-JC at 3:01 PM on Monday, April 12th, 2021
  • Announced that Oasis Digital Studios (“Oasis”) has partnered with Apex Comics Group to publish Mr. Right, a new multimedia project by legendary Marvel Entertainment and pop culture veterans Tom DeFalco, Ron Frenz, and Sal Buscema
  • Program will consist of printed and digital comic books, digital avatars produced for the Liquid Avatar Mobile App and Marketplace, and AR enhanced NFT collectibles with Oasis

TORONTO, ON and VANCOUVER, BC and ERIE, PA /April 12, 2021 / Liquid Avatar Technologies Inc. (CSE:LQID)(OTC PINK:TRWRF)(FRA:4T51) (“Liquid Avatar Technologies” or the “Company“,), a global blockchain, digital-identity and fintech solutions company, together with ImagineAR Inc. (IP) (IPNFF), an Augmented Reality platform company, are excited to announce that Oasis Digital Studios (“Oasis”) has partnered with Apex Comics Group to publish Mr. Right, a new multimedia project by legendary Marvel Entertainment and pop culture veterans Tom DeFalco, Ron Frenz, and Sal Buscema.

The program will consist of printed and digital comic books, digital avatars produced for the Liquid Avatar Mobile App and Marketplace, and AR enhanced NFT collectibles with Oasis. A sneak preview of the program will be made virtually on April 13th at the special presentation “NFTs Myths, Market, Media & Mania,” hosted by Liquid Avatar, ImagineAR and Oasis Digital Studios: https://hello.liquidavatar.com/oasis-webinar-registration.

The integrated campaign, expected to launch in early summer, will feature a series of limited-edition print and digital comic books, along with collector-enhanced NFTs, Liquid Avatar digital icons available in the Liquid Avatar Marketplace, and a fully immersive Augmented Reality multimedia program. A pre-sale waiting list is available for prospective purchasers and NFT collectors at the Oasis website: www.oasisdigitalstudios.com

Mr. Right is led by Tom DeFalco, who was Marvel’s 10th Editor-in-Chief. During his tenure, the company had the most successful fiscal and creative years in its entire eight-decade history. DeFalco was a driving force innovating the entire Marvel Universe with creative concepts used to this day in the Marvel Cinematic Universe. He also worked closely with the toy manufacturer Hasbro in the 1980s, heading the creative team that produced the backstory and dossiers that served as the basis for the relaunch of the phenomenally successful G.I. Joe toy line and animated television show.” DeFalco is the author of dozens of graphic novels and hundreds of comic-book stories, including The Amazing Spider-Man, Fantastic Four, Thor, Justice League of America, Archie, Scooby-Doo, and Dazzler, and with artist Ron Frenz created New Warriors and Spider-Girl.

DeFalco has personally created and developed over three dozen characters that have been licensed for television, toys, T-shirts, posters, trading cards and other merchandise, and has written Khan and The Phantom for Moonstone Books. In 1990, he won a Comic-Con International’s Inkpot Award, given to individuals for their contributions to the worlds of comics, science fiction/fantasy, film, television, animation, and fandom services.

For almost 40 years, renowned comic-book artist Ron Frenz has drawn some of the industry’s most iconic characters, including Spider-Man, Thor, Hulk, Captain America, Fantastic Four, Iron Man, She-Hulk, Silver Surfer, Green Lantern, Superman and, as previously mentioned, co-created New Warriors and Spider-Girl with Tom DeFalco. Frenz received the 2009 Nemo Award for Excellence in the Cartoon Arts.

Renowned artist, penciler and inker Sal Buscema has been a fixture in the comic-book industry for almost 60 years, primarily with Marvel, where he spent long runs as artist of The Avengers, The Defenders and The Incredible Hulk. Starting in the industry shortly after graduating high school in 1955, Buscema went on to work in a number of ventures, including the military as an illustrator and later with his brother, famed comic-book artist, John Buscema. With industry credits too long to list, he penciled and mostly inked a 100-issue run on The Spectacular Spider-Man from from 1988 to 1996, Buscema’s DC Comics artwork contributions include Action Comics, Batman, Catwoman, Detective Comics, Green Arrow, Superboy, Superman and Wonder Woman, among others. For Marvel, his contributions include The Amazing Spider-Man, The Avengers, Battlestar Galactica, Captain America, Daredevil, Doctor Strange, Ghost Rider, Iron Man, Master of Kung Fu, Silver Surfer, She-Hulk, Rom, Thor, X-Men, and many others. Buscema has collaborated on numerous occasions with both Frenz and DeFalco.

Buscema received the Inkpot Award in 2003 and the Hero Initiative Lifetime Achievement Award in September 2013 at the Baltimore Comic-Con. In 2013, he received the Inkwell Awards S.P.A.M.I. (Favorite Small Press and Mainstream-Independent) Award for his work on such titles as G.I. Joe Annual and Dungeons and Dragons: Forgotten Realms. In 2018, he was awarded the Inkwell Awards’ S.P.A.M.I. Award again, for his work on Rom.

“Apex Comics Group is incredibly fortunate to have Tom, Ron and Sal aboard to helm the creative direction for Mr. Right. As a lifelong fan of their work, I can’t wait for the world to see the new adventures they have dreamed up!” – Mariano Nicieza, Apex Comics Group President

Non-Fungible Tokens (NFT) are digital assets that represent a wide range of unique tangible and intangible items, from art, comic books and collectible sports cards to virtual real estate and even digital sneakers. One of the main benefits of owning a digital collectible versus a physical collectible like a rookie card or a rare-minted coin is that each NFT contains distinguishing information that makes it both distinct from any other NFT and easily verifiable. This makes the creation and circulation of fake collectibles pointless because each item can be traced back to the original issuer.

Mr. Right
Mr. Right is the world’s first NFT super-athlete. Witness the thrill-packed origin of this digital daredevil as he takes on the savage hordes of Big Brother. PLUS, in a bonus story: When video gamer Jeffery “Player One” Lopez’s detective mother is attacked by the Dead Presidents Gang, he turns to the one man who can bring her assailants to justice – Mr. Right, the new champion of split-second action!

“Ron, Sal and I are thrilled to be partnered with Liquid Avatar, Oasis Digital Studios and Apex Comics. NFTs, digital icons and comics are all poised to break new ground in the craft of visual storytelling, and we can’t wait to see what the future holds for all of us. Hoo-Ha and thanks for joining us!” – Tom DeFalco

The Oasis AR Enhanced NFT experience will be available exclusively through the Liquid Avatar Mobile App, which allows the user to create digital icons to manage, control and create value from their biometrically verified digital identity.It is available in the Google Play and Apple App stores.

If you would like to join our mailing list and receive updates from the Company., please click here

Read More: https://agoracom.com/ir/LiquidAvatar/forums/discussion/topics/758893-oasis-digital-studios-and-apex-comics-group-partner-with-comic-book-industry-legends-for-new-multimedia-experiences-and-nfts/messages/2311629#message

WeedMD $WMD $WDDMF to Host Fiscal Year-End 2020 Conference Call on April 30, 2021 $CRON $GTBIF $INDS $FAF.ca $WEED.ca

Posted by AGORACOM-JC at 9:16 AM on Friday, April 9th, 2021

  • Will file its financial statements and management’s discussion and analysis for the fourth quarter and fiscal year ended December 31, 2020, after market close on Thursday, April 29, 2021.
  • The Company will host a conference call to discuss these results, and provide an operational update on Friday, April 30, 2021 at 10 a.m. Eastern Time.

TORONTO, April 09, 2021 – WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, announced today that it will file its financial statements and management’s discussion and analysis for the fourth quarter and fiscal year ended December 31, 2020, after market close on Thursday, April 29, 2021. The Company will host a conference call to discuss these results, and provide an operational update on Friday, April 30, 2021 at 10 a.m. Eastern Time.

The call will be hosted by CEO and Executive Chairman George Scorsis and CFO Lincoln Greenidge. Management will be available for questions following opening remarks.

Conference Call Details:

Date:Friday, April 30 th , 2021
Time:10 a.m. Eastern Time
Dial-in Number:Canada/USA: 1-800-319-4610. International Toll: 1-604-638-5340
 Participants, please dial in and ask to join the WeedMD call
Replay Dial-in:Canada/USA: 1-800-319-6413. International Toll: 1-604-638-9010
 Replay Access Code: 6629
 Available after 12:00 p.m. Eastern Time, until May 30, 2021

Supplemental Listing of Warrants

WeedMD confirms that effective March 30, 2021, the TSX Venture Exchange (the “TSXV”) listed 19,046,875 common share purchase warrants (the “Warrants”) for trading under the symbol “ WMD.WT.A ” in connection with the Company’s previously announced bought deal short-form prospectus offering of units. Read here for more information.

Access WeedMD’s 2021 Shareholder Newsletter here . Updated investor presentation and corporate deck can be found here .

Read More: https://agoracom.com/ir/WeedMD/forums/discussion/topics/758782-weedmd-to-host-fiscal-year-end-2020-conference-call-on-april-30-2021/messages/2311374#message

KWESST $KWE.ca $KWEMF Announces Upsizing of Previously Announced Brokered Private Placement $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 8:37 AM on Friday, April 9th, 2021

  • Announce that in connection with its previously announced brokered private placement (the “Offering“), the Company and PI Financial Corp., the lead agent and sole bookrunner (the “Lead Agent“) for the Offering, have agreed to increase the size of the Offering to raise total gross proceeds of $4 million.
  • The Company now intends to issue 3,200,000 units of the Company (the “Units“) at a price of C$1.25 per Unit.
  • The 3,200,000 Units have been allocated to subscribers and the Offering is scheduled to close on or about April 29, 2021, or such date as agreed upon between the Company and the Lead Agent.
  • Given the upsize to the Offering, the parties have agreed to remove the previously announced over-allotment option.

Ottawa, Ontario–(April 9, 2021) – KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) (“KWESST” or “the Company”) is pleased to announce that in connection with its previously announced brokered private placement (the “Offering“), the Company and PI Financial Corp., the lead agent and sole bookrunner (the “Lead Agent“) for the Offering, have agreed to increase the size of the Offering to raise total gross proceeds of $4 million. The Company now intends to issue 3,200,000 units of the Company (the “Units“) at a price of C$1.25 per Unit. The 3,200,000 Units have been allocated to subscribers and the Offering is scheduled to close on or about April 29, 2021, or such date as agreed upon between the Company and the Lead Agent. Given the upsize to the Offering, the parties have agreed to remove the previously announced over-allotment option.

“The KWESST Offering was very well received by investors and resulted in significant demand for our financing, which led to the increase in size announced today. The proceeds will be used to accelerate our go-to market initiatives of KWESST’s various products,” said Jeffrey MacLeod, KWESST’s President and CEO. “One of our priorities is to finalize the acquisition of the Low Energy Cartridge (“LEC”) non-lethal system, which is expected to close concurrently with the Offering, after which we will begin the commercialization of this product. The Company has an accelerated plan to roll out the LEC product in response to market interest and high growth across all segments of the non-lethal market where a strong preference is being expressed for a safer, cartridge-based system over traditional systems such as Taser, beanbag shotgun shells and rubber bullets that can and do result in fatalities.”

Other corporate priorities to be funded with the proceeds from the Offering include the productization of the GreyGhost micro-drone missile, ramping up the Company’s ATAK Centre of Excellence business, and accelerating the productization of the Phantom electronic decoy.

Each Unit will be comprised of one common share of the Company (a “Common Share“) and one Common Share purchase warrant (“Warrant“). Each Warrant shall be exercisable to acquire one Common Share (a “Warrant Share“) at a price of C$1.75 per Warrant Share for a period of 24 months from the closing of the Offering. If at any time after four (4) months and one (1) day following the Closing Date, the trading price of the Shares on the TSX Venture Exchange is equal to or exceeds $3 for a period of 10 consecutive trading days, as evidenced by the price at the close of market, the Company shall be entitled to notify the holders of Warrants of its intention to force the exercise of the Warrants. Upon receipt of such notice, the holders of Warrants shall have 30 days to exercise the Warrants, failing which the Warrants will automatically expire.

The securities to be issued under the Offering will be offered by way of private placement in each of the provinces of Canada and such other jurisdictions as may be determined by the Company, in each case, pursuant to applicable exemptions from the prospectus requirements under applicable securities laws.

The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals including the approval of the Exchange. It is not a requirement for the closing of the Offering that the Company issues the entire 3,200,000 Units referenced above. The Units to be issued under the Offering will have a hold period of four months and one day from Closing.

The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“), or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.

Read More: https://agoracom.com/ir/Kwesst/forums/discussion/topics/758779-kwesst-announces-upsizing-of-previously-announced-brokered-private-placement/messages/2311369#message

KWESST $KWE.ca $KWEMF Releases Video and Photos Of TASCS IFM For 81 mm Mortar in U.S. Military Exercises $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 8:25 AM on Thursday, April 8th, 2021
  • Release approved footage and pictures of the KWESST TASCS Integrated Fires Module (“IFM”) in action in live-fire exercises at a U.S. military base.
  • These exercises are being held pursuant to a contract with a key U.S. military customer
  • Video and photos depict the TASCS IFM system fitted on the 81 mm mortar and firing at a range of 2,600 metres.

Ottawa, Ontario–(April 8, 2021) – KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) (“KWESST” or “the Company”) is pleased to release approved footage and pictures of the KWESST TASCS Integrated Fires Module (“IFM”) in action in live-fire exercises at a U.S. military base. These exercises are being held pursuant to a contract with a key U.S. military customer (for further information please see the December 2020 news release at https://kwesst.com/news/kwesst-announces-c1-1-million-follow-on-order-for-tascs-ifm-from-key-u-s-military-customer-2/ ) which is currently being delivered.



Cannot view this video? Visit:
https://www.youtube.com/watch?v=K4oOEczVOkM

The pictures are available at: https://kwesst.com/systems/tascs-ifm/

The video and photos depict the TASCS IFM system fitted on the 81 mm mortar and firing at a range of 2,600 metres. With TASCS IFM, the mortar team is able to acquire targets in 15 seconds compared to the traditional 15 minutes, and engage targets with unprecedented accuracy. The 81mm mortar is just one of many firing platforms that can be fitted with the TASCS IFM systems and requires no modification of the firing platform or ammunition. It effectively turns a traditional “dumb” firing platform into a “smart” weapons system by providing soldiers on the ground with real-time networked situational awareness and precision targeting information.

About KWESST

KWESST develops and commercializes high-value ultra-miniaturized technology applications that make a critical difference to the safety and operational effectiveness of personnel in the defence and security industries. The company’s current portfolio of unique proprietary offerings include: its signature TASCSTM (Tactical Awareness and Situational Control System) for real-time awareness and targeting information from any source (including drones) streamed directly to users’ smart devices and weapons; the autonomous GreyGhostTM soldier-portable micro drone missile system that defends against small hostile drones including swarms using high-speed kinetic impact; a Ground Laser Defence system to counter the emerging threat of weaponized lasers against personnel; and, the PhantomTM electronic battlefield decoy system to mask the electromagnetic signature of friendly forces with decoy signatures at false locations to deceive and confuse adversaries. All systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems including Frontline, Edge, Killswitch and ATAK (Android Tactical Assault Kit) among others. KWESST also has developmental “smart ordnance” projects including its “Shot Counter” system, which records the number and type of rounds fired, for optimized firearms maintenance and performance. The Company is headquartered in Ottawa, Canada, with representative offices in Washington, DC, London, UK and Abu Dhabi, UAE. KWESST trades on the TSX Venture Exchange under the symbol KWE and on the U.S. OTCQB under the symbol KWEMF.

Read More: https://agoracom.com/ir/Kwesst/forums/discussion/topics/758710-kwesst-releases-video-and-photos-of-tascs-ifm-for-81-mm-mortar-in-u-s-military-exercises/messages/2311218#message

Empower Clinics $CBDT.ca $EPWCF Partners with Leading U.S. Digital Marketing Agency to Launch Direct-to-Consumer e-Commerce Solutions $DMTK $LMD.ca $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM-JC at 8:19 AM on Thursday, April 8th, 2021

Snow Agency recognized as #1 U.S. digital marketing agency

  • Announced a partnership with Snow Agency to launch its direct-to-consumer (DTC) e-commerce solutions.
  • Snow Agency is a performance digital marketing and creative agency whose customized brand strategies and content production maximize the impact of direct response ads and creatives on Facebook/Instagram, Google/YouTube, Snapchat, and Email/SMS
  • Collaboration will allow Empower patients, existing and prospective, to benefit from an accessible, seamless and educative experience when purchasing at-home diagnostics test kits

VANCOUVER BC / April 8, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens – today announced a partnership with Snow Agency to launch its direct-to-consumer (DTC) e-commerce solutions.

The Snow Agency is a performance digital marketing and creative agency whose customized brand strategies and content production maximize the impact of direct response ads and creatives on Facebook/Instagram, Google/YouTube, Snapchat, and Email/SMS. To date, they’ve brought in more than $250 million USD in sales for their clients. The Snow Agency has been recognized on Yahoo! Finance ranked as the #1 US Digital Marketing Agency & Digital Agency in January 2021 by Design Rush, a top B2B marketplace connecting brands with agencies.

The collaboration will allow Empower patients, existing and prospective, to benefit from an accessible, seamless and educative experience when purchasing at-home diagnostics test kits. Today patients can purchase at-home COVID-19 saliva test kits by phone or email at www.kaitests.com.

“Empower is committed to make our solutions as convenient as possible to all patients in North America. A DTC e-commerce solution is a key part of that solution.” said Steven McAuley, Chairman & CEO of Empower. “I am privileged to now count Snow Agency as a partner in our journey to deliver at-home testing solutions and empower patients to take control of their own health data. Even with vaccines, ongoing testing is desperately needed because more testing, along with mask-wearing and physical distancing, will get people back into offices, planes and classrooms and help catch cases that go undetected”.

“This partnership is really making a positive difference in people’s lives. We know that we can reach millions of consumers with success for brands. We see our partnership with Empower as our contribution from Snow Agency to help reopen the economy, allow people to travel with confidence and getting back to normal life.” said Dan Snow, CEO and Co-founder of Snow Agency.

“As a trained physician and a digital marketing entrepreneur, I fully believe in Empower’s at-home diagnostic testing solutions especially its integrated laboratory services at Kai Medical. It’s the time now to digitally transform healthcare, focus on accessibility and convenience for patients and save valuable time and money on stretched public health services. People will need to get tested regularly so we can all get back to normal” said Dr. Jonathan Snow, COO and Co-founder of Snow Agency.

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

ABOUT EMPOWER:

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors:
Steven McAuley CEO
[email protected]
604-789-2146

Investors:
Tamara Mason
Business Development & Communications
[email protected]
416-671-5617

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the expected benefits to the Company and its shareholders as a result of the acquisition of Kai Medical Laboratory; the transaction terms; the expected number of clinics and patients following the closing; the future potential success of Kai Medical Laboratory, Sun Valley’s franchise model; launch of new healthcare centers and the occurrence thereof; that the Company can bring healthcare to millions of Canadians; that new healthcare services can be added and that the Company will be positioned to be a market- leading service provider for complex patient requirements in 2020 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that Kai Medical Laboratory will successfully win any US Government RFP; that the MedX Health pilot program will be successful; that Empower will place the MedX Health teledermatology product in health centers in North America; that the Company’s products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; that the Company will be able to commence and/or complete build-outs and tenants improvements for Canadian clinics or Kai Medical Laboratory expansion inn 2Q 2021; that general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Else $BABY.ca $BABYF to launch product rollout to “Big Y” stores in April $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 8:03 AM on Wednesday, April 7th, 2021
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Announced that it will begin its Northeast rollout by mid April 2021 , through “Big Y” World Class Markets, out of Springfield Massachusetts
  • Else’s Plant-Based Nutrition for Toddlers will be available for purchase in all 71 Big Y grocery stores.

VANCOUVER, BC , April 7, 2021 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company , announces that it will begin its Northeast rollout by mid April 2021 , through “Big Y” World Class Markets, out of Springfield Massachusetts . Else’s Plant-Based Nutrition for Toddlers will be available for purchase in all 71 Big Y grocery stores.

“Launching with Big Y represents another exciting milestone for Else,” said Hamutal Yitzhak , Else CEO and Co-Founder. “The northeast population size is paramount to the growth of our brand. Big Y’s large-format shelves and health-minded shoppers represent an opening into the progressive New England customer-base. We are eager to bring real, whole food-based, clean label solutions to families in this region,” she added.

About Big Y

Big Y is one of the largest independently owned supermarket chains in New England , and it employs over 12,000 people. In 2020 Big Y was the 210th-largest private company in the United States , according to that year’s Forbes magazine “500 Largest Private Companies” list. As of October 2020 , Big Y operates 71 supermarkets in Massachusetts and Connecticut ; [1] [3] many of which are located in the metropolitan areas of Springfield , Worcester , Greater Boston , and Hartford . In addition to its traditional supermarkets, Big Y owns and operates two specialty markets: Table & Vine, a large specialty liquor and wine store in West Springfield ; and the Fresh Acres Market, a concept mixing an open-air-style farmers’ market with upscale food choices, in Springfield . Big Y also operated two standalone pharmacies in Springfield and Wilbraham before eventually folding them into the pharmacies located in its nearby stores.